• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对经胆汁循环的药物给药后获得的浓度-时间数据进行药代动力学分析。

Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.

作者信息

Colburn W A

出版信息

J Pharm Sci. 1984 Mar;73(3):313-7. doi: 10.1002/jps.2600730308.

DOI:10.1002/jps.2600730308
PMID:6585546
Abstract

A pharmacokinetic model for calculating the pharmacokinetic parameters for a compound that is recycled in the bile is presented and tested using theoretical as well as experimental data. The results indicate that this method is stable and only slightly susceptible to sampling and recycling times. It is apparent from the present study that pharmacokinetic terms that have been used in classical situations are not directly applicable to drugs that enter the enterohepatic circulation. Effective half-life and effective clearance are used to describe the intrinsic ability of the eliminating organs to remove drug from the blood, whereas net half-life and net clearance are used to describe the irreversible elimination of the drug from the body.

摘要

提出了一种用于计算经胆汁循环的化合物药代动力学参数的药代动力学模型,并使用理论数据和实验数据进行了测试。结果表明,该方法稳定,仅对采样时间和循环时间略有敏感。从本研究中可以明显看出,经典情况下使用的药代动力学术语并不直接适用于进入肠肝循环的药物。有效半衰期和有效清除率用于描述消除器官从血液中清除药物的内在能力,而净半衰期和净清除率则用于描述药物从体内的不可逆消除。

相似文献

1
Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.对经胆汁循环的药物给药后获得的浓度-时间数据进行药代动力学分析。
J Pharm Sci. 1984 Mar;73(3):313-7. doi: 10.1002/jps.2600730308.
2
A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.药物及其共轭代谢物对肝肠循环的可逆清除模型。
Drug Metab Dispos. 1990 Jan-Feb;18(1):80-7.
3
Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.估算经历肠肝循环的药物的重吸收分数。
J Pharmacokinet Biopharm. 1982 Aug;10(4):455-61. doi: 10.1007/BF01065175.
4
Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.给药途径和胆汁排泄对异维A酸在犬体内药代动力学的影响。
Drug Metab Dispos. 1984 Mar-Apr;12(2):143-7.
5
Role of enterohepatic recirculation in drug disposition: cooperation and complications.肠肝循环在药物处置中的作用:合作与并发症。
Drug Metab Rev. 2016 May;48(2):281-327. doi: 10.3109/03602532.2016.1157600. Epub 2016 Mar 18.
6
Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling.分析考虑肠肝循环时肝脏中复杂药物相互作用引起的血药浓度-时间曲线变化:通过使用基于生理的药代动力学模型分析来考察摄取、代谢和胆汁排泄的抑制常数是否可以被恢复。
J Pharm Sci. 2017 Sep;106(9):2727-2738. doi: 10.1016/j.xphs.2017.04.057. Epub 2017 May 4.
7
Effect modelling for drugs undergoing enterohepatic circulation.进行肠肝循环的药物的效应建模。
Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):333-8. doi: 10.1007/BF03190182.
8
Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.健康志愿者及带胆汁T管引流志愿者体内14C-异维A酸的药代动力学
Drug Metab Dispos. 1985 May-Jun;13(3):327-32.
9
Pharmacokinetic and biopharmaceutic parameters during enterohepatic circulation of drugs.药物肝肠循环过程中的药代动力学和生物药剂学参数。
J Pharm Sci. 1982 Jan;71(1):131-3. doi: 10.1002/jps.2600710139.
10
Pharmacokinetics of isotretinoin following a single oral dose.
J Clin Pharmacol. 1982 Aug-Sep;22(8-9):395-402. doi: 10.1002/j.1552-4604.1982.tb02692.x.

引用本文的文献

1
The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms.多次给药的半衰期:定义患者体内药物蓄积及设计缓释剂型的关键。
Pharm Res. 2008 Dec;25(12):2869-77. doi: 10.1007/s11095-008-9787-9. Epub 2008 Nov 18.
2
Preclinical pharmacology of the antitumor agent O-6-methylguanine in CDF1 mice.抗肿瘤药物O-6-甲基鸟嘌呤在CDF1小鼠中的临床前药理学研究
Cancer Chemother Pharmacol. 1993;33(3):197-202. doi: 10.1007/BF00686216.
3
Effect modelling for drugs undergoing enterohepatic circulation.
进行肠肝循环的药物的效应建模。
Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):333-8. doi: 10.1007/BF03190182.
4
Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam.影响两种苯并噻嗪类非甾体抗炎药(吡罗昔康和异恶酰胺)动力学的因素。
Eur J Clin Pharmacol. 1985;28(6):689-92. doi: 10.1007/BF00607917.
5
Estimation of area under the curve for drugs subject to enterohepatic cycling.对经历肠肝循环的药物的曲线下面积的估算。
J Pharmacokinet Biopharm. 1985 Dec;13(6):589-608. doi: 10.1007/BF01058903.
6
The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat.
Eur J Drug Metab Pharmacokinet. 1985 Oct-Dec;10(4):333-41. doi: 10.1007/BF03189762.
7
Mean residence time for drugs subject to enterohepatic cycling.经历肠肝循环的药物的平均驻留时间。
J Pharmacokinet Biopharm. 1989 Jun;17(3):327-45. doi: 10.1007/BF01061900.
8
Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT).通过快速拉普拉斯逆变换(FILT)分析大鼠体内头孢克肟的肠肝循环。
J Pharmacokinet Biopharm. 1990 Dec;18(6):545-59. doi: 10.1007/BF01073938.
9
Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.生理和代谢对肝肠循环的影响:基于丙戊酸在大鼠体内处置情况的模拟
J Pharmacokinet Biopharm. 1991 Apr;19(2):189-225. doi: 10.1007/BF01073869.
10
General treatment of the enterohepatic recirculation of drugs and its influence on the area under the plasma level curves, bioavailability, and clearance.药物肝肠循环的一般处理及其对血浆浓度曲线下面积、生物利用度和清除率的影响。
Pharm Res. 1992 Oct;9(10):1306-13. doi: 10.1023/a:1015861502354.